Laddar...
Combined treatment of vitamin K(2) and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis
Although it is well known that the hepatocellular carcinoma (HCC) is an ominous complication in patients with liver cirrhosis, there has been no approved drug to prevent the development of HCC to date. We previously reported that the combined treatment of vitamin K(2) (VK) and angiotensin-converting...
Sparad:
| I publikationen: | World J Gastroenterol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Co., Limited
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436616/ https://ncbi.nlm.nih.gov/pubmed/17589909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i23.3259 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|